United States · Biotechnology startup
United States · Singulex
Singulex develops direct molecular detection technology, cardiovascular monitoring, and related solutions to understand and manage diseases.
Funding reportedLast round: Debt financing
Follow Singulex and see its new rounds in your feed.Start following
What company datasets say Singulex raised
Funding, as reported
Reported in all$227Min dollars
Rounds9
Last roundDebt financing
Last round dateApr 2017
Investors listed11
SEC Form D$45M sold, 4 filings, last Jun 2013
Founders and team
From the SEC filings it signed: 2 on the team.
- Guido L. BaechlerExecutive Officer, Directori
- Michael K. BellExecutive Officeri
On the board, as filediAndre R. MarionCarl L. GordonFred K. VogtGregory R. JohnsonHeiner J. DreismannPhilippe J. GoixR. Douglas K. NorbyStephen L. Rose
Biotechnology in United States
Startups like it
- SojournixWaltham · founded 2016Raised
- Receptor Life SciencesSeattle · founded 2017Raised
- Attune PharmaceuticalsNew York · founded 2018Raised
AbbVieNorth Chicago · founded 2012
GrailMenlo Park · founded 2015
EQRxCambridge · founded 2019- Cerevel TherapeuticsBoston · founded 2018
Royalty PharmaNew York · founded 1996
Is this your company?
Add your raise, your deck and your story, and put Singulex in front of investors. Or tell us what we have wrong.